Medigen Vaccine Biologics Corporation (6547.TWO)
TWD 42.7
(6.48%)
TWD 42.7
(6.48%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 621.53 Million TWD | -17.38% |
| 2022 | 752.3 Million TWD | 163.11% |
| 2021 | -1.19 Billion TWD | 20.05% |
| 2020 | -1.49 Billion TWD | -455.27% |
| 2019 | 419.69 Million TWD | 36.79% |
| 2018 | 306.81 Million TWD | 915.64% |
| 2017 | -37.61 Million TWD | -253.14% |
| 2016 | 24.56 Million TWD | 108.44% |
| 2015 | -291.01 Million TWD | -248.87% |
| 2014 | -83.41 Million TWD | 74.25% |
| 2013 | -324 Million TWD | -714.77% |
| 2012 | -39.76 Million TWD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -40.19 Million TWD | 53.91% |
| 2024 Q1 | -1.65 Billion TWD | -366.94% |
| 2023 Q1 | 939.07 Million TWD | 24.83% |
| 2023 Q3 | 1.43 Billion TWD | 11.71% |
| 2023 Q2 | 1.28 Billion TWD | 36.43% |
| 2023 Q4 | 621.53 Million TWD | -56.57% |
| 2023 FY | 621.53 Million TWD | -17.38% |
| 2022 Q4 | 752.3 Million TWD | -6.53% |
| 2022 Q3 | 804.86 Million TWD | 131.33% |
| 2022 Q2 | -2.56 Billion TWD | -161.76% |
| 2022 FY | 752.3 Million TWD | 163.11% |
| 2022 Q1 | -981.31 Million TWD | 17.68% |
| 2021 Q2 | -654.5 Million TWD | -241.09% |
| 2021 FY | -1.19 Billion TWD | 20.05% |
| 2021 Q4 | -1.19 Billion TWD | -90.35% |
| 2021 Q1 | -191.88 Million TWD | 87.13% |
| 2021 Q3 | -626.26 Million TWD | 4.31% |
| 2020 Q4 | -1.49 Billion TWD | -495.91% |
| 2020 FY | -1.49 Billion TWD | -455.27% |
| 2020 Q1 | 409.08 Million TWD | -2.53% |
| 2020 Q2 | 491.17 Million TWD | 20.07% |
| 2020 Q3 | 376.6 Million TWD | -23.32% |
| 2019 FY | 419.69 Million TWD | 36.79% |
| 2019 Q2 | 695.45 Million TWD | 19.97% |
| 2019 Q3 | 595.87 Million TWD | -14.32% |
| 2019 Q4 | 419.69 Million TWD | -29.57% |
| 2019 Q1 | 579.67 Million TWD | 88.93% |
| 2018 Q4 | 306.81 Million TWD | 74.12% |
| 2018 FY | 306.81 Million TWD | 915.64% |
| 2018 Q3 | 176.21 Million TWD | 143.6% |
| 2018 Q2 | -404.17 Million TWD | -926.36% |
| 2018 Q1 | 48.91 Million TWD | 230.02% |
| 2017 Q3 | -112.5 Million TWD | -167.59% |
| 2017 Q2 | 166.44 Million TWD | -46.3% |
| 2017 Q1 | 309.97 Million TWD | 1161.9% |
| 2017 FY | -37.61 Million TWD | -253.14% |
| 2017 Q4 | -37.61 Million TWD | 66.56% |
| 2016 Q1 | 105.02 Million TWD | 136.09% |
| 2016 Q2 | 87.37 Million TWD | -16.8% |
| 2016 Q4 | 24.56 Million TWD | 0.0% |
| 2016 FY | 24.56 Million TWD | 108.44% |
| 2015 Q3 | -274.44 Million TWD | -331.77% |
| 2015 Q1 | 116.45 Million TWD | 239.61% |
| 2015 Q2 | 118.41 Million TWD | 1.68% |
| 2015 FY | -291.01 Million TWD | -248.87% |
| 2015 Q4 | -291.01 Million TWD | -6.04% |
| 2014 FY | -83.41 Million TWD | 74.25% |
| 2014 Q1 | 326.91 Million TWD | 0.0% |
| 2014 Q3 | -83.95 Million TWD | 0.0% |
| 2014 Q4 | -83.41 Million TWD | 0.64% |
| 2013 FY | -324 Million TWD | -714.77% |
| 2012 FY | -39.76 Million TWD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Sagittarius Life Science Corp | -120.57 Million TWD | 615.498% |
| Neith Corporation | -150.31 Million TWD | 513.5% |
| TaiRx, Inc. | -147.86 Million TWD | 520.329% |
| BioGend Therapeutics Co., Ltd. | -317.41 Million TWD | 295.81% |
| Shine-On BioMedical Co.,Ltd. | -101.48 Million TWD | 712.435% |
| Great Novel Therapeutics Biotech & Medicals | -165.17 Million TWD | 476.287% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | -264.16 Million TWD | 335.28% |
| NeoCore Technology Co., Ltd. | -196.39 Million TWD | 416.469% |
| GeneReach Biotechnology Corp. | 40.26 Million TWD | -1443.575% |
| Genomics BioSci & Tech. Co.,Ltd. | 30.57 Million TWD | -1932.625% |
| Visgeneer Inc. | 31.28 Million TWD | -1886.754% |
| Sunmax Biotechnology Co., Ltd. | -680.6 Million TWD | 191.321% |
| G&E Herbal Biotechnology Co., Ltd. | -134.25 Million TWD | 562.962% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -57.65 Million TWD | 1177.97% |
| Enimmune corporation | -314.15 Million TWD | 297.841% |
| EirGenix Inc. | -4.58 Billion TWD | 113.547% |
| BioLASCO Taiwan Co., Ltd. | -84.76 Million TWD | 833.263% |
| Sunny Pharmtech Inc. | 120.87 Million TWD | -414.214% |
| Feng Chi Biotech Corp. | -19.81 Million TWD | 3237.011% |
| Lukas Biomedical Inc. | 50.75 Million TWD | -1124.581% |
| RBC Bioscience Corporation | 422.18 Million TWD | -47.219% |
| BiOptic Inc. | 12.59 Million TWD | -4835.959% |
| Anti-Microbial Savior BioteQ Co., Ltd | -77.04 Million TWD | 906.729% |
| Syngen Biotech Co.,Ltd. | 314.87 Million TWD | -97.393% |
| Mycenax Biotech Inc. | 207 Million TWD | -200.246% |
| Bio Preventive Medicine Corp. | 31.8 Million TWD | -1853.963% |
| Level Biotechnology Inc. | -453.9 Million TWD | 236.931% |
| TaiMed Biologics Inc. | 499.84 Million TWD | -24.345% |
| GlycoNex Incorporation | -148.56 Million TWD | 518.354% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 137.99 Million TWD | -350.405% |
| SynCore Biotechnology Co.,Ltd | -262.58 Million TWD | 336.702% |
| Lin BioScience, Inc. | -3.21 Billion TWD | 119.313% |
| BRIM Biotechnology, Inc. | -944.4 Million TWD | 165.812% |
| VBI | -25.31 Million TWD | 2555.111% |
| CHO Pharma, Inc. | -203.79 Million TWD | 404.985% |
| Advagene Biopharma Co., Ltd. | -64.32 Million TWD | 1066.303% |
| NaviFUS Corp. | -123.12 Million TWD | 604.784% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 74.05 Million TWD | -739.335% |
| Sinew Pharma Inc. | -160.34 Million TWD | 487.624% |
| Andros Pharmaceuticals Co.,Ltd | -241.89 Million TWD | 356.947% |
| Greenyn Biotechnology Co., Ltd | -337.37 Million TWD | 284.228% |
| Lumosa Therapeutics Co., Ltd. | -412.63 Million TWD | 250.625% |
| AP Biosciences Inc | -196.52 Million TWD | 416.258% |
| Medigen Biotechnology Corp. | 688.73 Million TWD | 9.757% |
| 3D Global Biotech Inc. | -11.43 Million TWD | 5534.432% |
| Pharmosa Biopharm Inc. | -829.69 Million TWD | 174.912% |
| Intech Biopharm Corporation | 1.35 Billion TWD | 54.209% |
| Oneness Biotech Co., Ltd. | -414.87 Million TWD | 249.812% |
| Eusol Biotech Co.,Ltd. | -209.33 Million TWD | 396.905% |
| TWi Biotechnology, Inc. | -143.86 Million TWD | 532.033% |
| Ever Supreme Bio Technology Co., Ltd | -330.54 Million TWD | 288.035% |
| TCI GENE Inc. | -689.25 Million TWD | 190.176% |
| MegaPro Biomedical Co., Ltd | -118.93 Million TWD | 622.571% |
| Senhwa Biosciences, Inc. | -1.3 Billion TWD | 147.474% |
| Taiwan Bio Therapeutics Co., Ltd | 20.48 Million TWD | -2934.399% |
| NatureWise Biotech & Medicals Corporation | -101.87 Million TWD | 710.127% |
| PharmaEngine, Inc. | -860.8 Million TWD | 172.204% |
| Savior Lifetec Corporation | -812.54 Million TWD | 176.493% |
| TaiGen Biopharmaceuticals Holdings Limited | -299.96 Million TWD | 307.201% |
| OBI Pharma, Inc. | -398.22 Million TWD | 256.077% |
| Meribank Biotech Co., Ltd | -365.41 Million TWD | 270.089% |
| Acepodia, Inc. | -6.02 Billion TWD | 110.324% |
| Caliway Biopharmaceuticals Co., Ltd. | -3.4 Billion TWD | 118.271% |